Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure. [electronic resource]
Producer: 20160225Description: 11482-99 p. digitalISSN:- 1422-0067
- Animals
- Benzamides -- pharmacology
- Cicatrix
- Collagen -- metabolism
- Connective Tissue Growth Factor -- genetics
- Disease Models, Animal
- Fibroblasts -- drug effects
- Fibronectins -- metabolism
- Fibrosis
- Gene Expression
- Heart Failure -- etiology
- Histone Deacetylase Inhibitors -- pharmacology
- Histone Deacetylases -- metabolism
- Interleukin-6 -- metabolism
- Myocardial Ischemia -- complications
- Pyrimidines -- pharmacology
- Rats
- STAT3 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
- Ventricular Function -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.